why choose us

First received: October 23, 2023

Clinical Trial: A Study of [14C]-LOXO-783 in Healthy Adult Participants

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Two-part Study of the Absorption, Metabolism, Excretion, and the Absolute Bioavailability of [14C]-LOXO-783 in Healthy Adult Subjects

Brief Summary: The main purpose of this study is to evaluate how much of the study drug, the radioactive substance 14C incorporated LOXO-783 ([¹?C]-LOXO-783) passes from blood into urine, feces and expired air in healthy adult participants when administered as a single dose.The study will also measure how much of the LOXO-783 and [¹?C]-LOXO-783 gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it.The study is conducted in two parts and will last up to approximately 72 and 61 days for…

Read more